BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved Orthopedic Use of BPC 157 Sports Med Review FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification